allograft

(redirected from allograft rejection)
Also found in: Thesaurus, Medical, Encyclopedia.

al·lo·graft

 (ăl′ə-grăft′)
n.
A tissue or organ graft between genetically different individuals of the same species, as between two humans. Also called homograft.

al′lo·graft′ v.

allograft

(ˈæləʊˌɡrɑːft)
n
(Medicine) a tissue graft from a donor genetically unrelated to the recipient

al•lo•graft

(ˈæl əˌgræft, -ˌgrɑft)

n.
a tissue or organ obtained from one member of a species and grafted to a genetically dissimilar member of the same species. Also called homograft.
[1960–65]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.allograft - tissue or organ transplanted from a donor of the same species but different genetic makeupallograft - tissue or organ transplanted from a donor of the same species but different genetic makeup; recipient's immune system must be suppressed to prevent rejection of the graft
graft, transplant - (surgery) tissue or organ transplanted from a donor to a recipient; in some cases the patient can be both donor and recipient
Translations

al·lo·graft

n. aloinjerto. V.: homograft.

allograft

n aloinjerto
References in periodicals archive ?
The sNDA is based on data from multinational phase 3 study LCP-Tacro 3002, which evaluated the safety and efficacy of Envarsus XR compared to immediate-release tacrolimus capsules for the prevention of acute allograft rejection in over 500 de novo adult kidney transplant recipients.
In conjunction, the sNDA is based on data from the company's multinational phase 3 study LCP-Tacro 3002, which evaluated the safety and efficacy of Envarsus XR versus immediate-release tacrolimus capsules for the prevention of acute allograft rejection in 500 de novo adult kidney transplant recipients.
The study found that dd-cfDNA may be used to assess allograft rejection and injury; levels > 1% indicate a high probability of ABMR.
Allograft rejection is a serious complication in lung transplant because of potential acute graft dysfunction or failure and/or subsequent complications that can lead to chronic graft failure.
The principle challenge in kidney transplantation is the suppression of allograft rejection.
Pathology results "were reminiscent of those observed in patients with acute allograft rejection after cardiac transplantation," Dr.
Therefore, coltelizumab is a genuine non-mitogenic version of anti-CD3 antibody and can be used to treat acute allograft rejection and autoimmune diseases with greater drug potency and lower side effect than the current low-mitogenic versions in clinical trials.
The renal needle biopsies, though a mainstay for kidney transplant diagnosis of acute allograft rejection, are invasive and are compromised by sampling heterogeneity and subjective interpretation.
It is an established invasive clinical tool used for surveillance of cardiac allograft rejection and, to a lesser extent, in the evaluation of dilated and restrictive cardiomyopathies2.
The major obstacle of allogeneic transplantation is the allograft rejection due to mismatched major histocompatibility complex (MHC) antigens [1, 2].
Combined analysis of allograft inflammatory factor-1, interleukin-18 and Toll-like receptor expression and association with allograft rejection and coronary vasculopathy.